

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fc-gamma receptor signaling pathway (GO:0038094) | 9.42217666 |
| 2 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 9.42217666 |
| 3 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 9.42217666 |
| 4 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 9.31246173 |
| 5 | retina homeostasis (GO:0001895) | 8.29400690 |
| 6 | humoral immune response (GO:0006959) | 7.43556301 |
| 7 | negative regulation of B cell proliferation (GO:0030889) | 6.29475653 |
| 8 | negative regulation of B cell apoptotic process (GO:0002903) | 6.25192399 |
| 9 | purine nucleotide salvage (GO:0032261) | 6.10921335 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 6.08193830 |
| 11 | seminiferous tubule development (GO:0072520) | 5.79711644 |
| 12 | signal peptide processing (GO:0006465) | 5.54002805 |
| 13 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.45996495 |
| 14 | B cell receptor signaling pathway (GO:0050853) | 5.34819333 |
| 15 | mucosal-associated lymphoid tissue development (GO:0048537) | 5.33114420 |
| 16 | Peyers patch development (GO:0048541) | 5.33114420 |
| 17 | fucose catabolic process (GO:0019317) | 5.18560527 |
| 18 | L-fucose metabolic process (GO:0042354) | 5.18560527 |
| 19 | L-fucose catabolic process (GO:0042355) | 5.18560527 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.17230280 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.01221671 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01221671 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.01007611 |
| 24 | negative regulation of T-helper cell differentiation (GO:0045623) | 5.00589887 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 5.00589887 |
| 26 | regulation of B cell differentiation (GO:0045577) | 4.99881241 |
| 27 | negative regulation of glucose import (GO:0046325) | 4.98368352 |
| 28 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 4.79373653 |
| 29 | deoxyribonucleotide catabolic process (GO:0009264) | 4.79097998 |
| 30 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.78755321 |
| 31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.74360918 |
| 32 | purine deoxyribonucleotide metabolic process (GO:0009151) | 4.70897844 |
| 33 | cellular response to zinc ion (GO:0071294) | 4.60489985 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.59619129 |
| 35 | deoxyribose phosphate catabolic process (GO:0046386) | 4.59384463 |
| 36 | histamine secretion (GO:0001821) | 4.57825866 |
| 37 | regulation of B cell apoptotic process (GO:0002902) | 4.53487346 |
| 38 | regulation of germinal center formation (GO:0002634) | 4.38783985 |
| 39 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 4.32279599 |
| 40 | regulation of B cell proliferation (GO:0030888) | 4.20683047 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18728328 |
| 42 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.09867273 |
| 43 | negative regulation of glucose transport (GO:0010829) | 4.06226995 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05898698 |
| 45 | regulation of penile erection (GO:0060405) | 4.03034858 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 4.02357721 |
| 47 | nucleotide salvage (GO:0043173) | 3.95560169 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.94959070 |
| 49 | purine-containing compound salvage (GO:0043101) | 3.93135373 |
| 50 | Fc receptor signaling pathway (GO:0038093) | 3.91279121 |
| 51 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.89520130 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.88362096 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.86275048 |
| 54 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.82809391 |
| 55 | base-excision repair, AP site formation (GO:0006285) | 3.81756122 |
| 56 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.81409719 |
| 57 | autophagic vacuole fusion (GO:0000046) | 3.68119603 |
| 58 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.66525721 |
| 59 | cellular hyperosmotic response (GO:0071474) | 3.65638852 |
| 60 | immune response-activating signal transduction (GO:0002757) | 3.63444518 |
| 61 | regulation of respiratory burst (GO:0060263) | 3.62490572 |
| 62 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.62204945 |
| 63 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.60586157 |
| 64 | histamine transport (GO:0051608) | 3.54229365 |
| 65 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.54113561 |
| 66 | negative regulation of type 2 immune response (GO:0002829) | 3.53812884 |
| 67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.53296625 |
| 68 | peptidyl-asparagine modification (GO:0018196) | 3.51304256 |
| 69 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.49982569 |
| 70 | mitochondrial calcium ion transport (GO:0006851) | 3.49105443 |
| 71 | angiogenesis involved in wound healing (GO:0060055) | 3.47963896 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.46031802 |
| 73 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.45511679 |
| 74 | B cell mediated immunity (GO:0019724) | 3.45237938 |
| 75 | deoxyribose phosphate metabolic process (GO:0019692) | 3.43337698 |
| 76 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.42797695 |
| 77 | response to protozoan (GO:0001562) | 3.41430256 |
| 78 | mannose metabolic process (GO:0006013) | 3.39967307 |
| 79 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.38042957 |
| 80 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.37513078 |
| 81 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.36725450 |
| 82 | positive regulation of response to oxidative stress (GO:1902884) | 3.34096082 |
| 83 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.34096082 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 3.33162680 |
| 85 | organelle membrane fusion (GO:0090174) | 3.33070314 |
| 86 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.32864429 |
| 87 | sialylation (GO:0097503) | 3.32133395 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 3.28872957 |
| 89 | adenosine metabolic process (GO:0046085) | 3.28291550 |
| 90 | positive regulation of prostaglandin secretion (GO:0032308) | 3.27973273 |
| 91 | activation of immune response (GO:0002253) | 3.27049016 |
| 92 | UV protection (GO:0009650) | 3.26784639 |
| 93 | endothelium development (GO:0003158) | 3.26498278 |
| 94 | defense response to protozoan (GO:0042832) | 3.25872720 |
| 95 | protein N-linked glycosylation (GO:0006487) | 3.24331556 |
| 96 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.21706244 |
| 97 | positive regulation of immunoglobulin production (GO:0002639) | 3.20542877 |
| 98 | negative regulation of B cell activation (GO:0050869) | 3.18749260 |
| 99 | megakaryocyte development (GO:0035855) | 3.13307744 |
| 100 | regulation of B cell activation (GO:0050864) | 3.12361738 |
| 101 | glomerular filtration (GO:0003094) | 3.09925457 |
| 102 | ganglioside metabolic process (GO:0001573) | 3.08064179 |
| 103 | B cell homeostasis (GO:0001782) | 3.08037075 |
| 104 | deoxyribonucleotide metabolic process (GO:0009262) | 3.07975190 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.07054819 |
| 106 | dendritic cell chemotaxis (GO:0002407) | 3.05105391 |
| 107 | negative thymic T cell selection (GO:0045060) | 3.04329493 |
| 108 | negative regulation of osteoclast differentiation (GO:0045671) | 3.01311669 |
| 109 | complement activation, classical pathway (GO:0006958) | 20.6968655 |
| 110 | positive regulation of respiratory burst (GO:0060267) | 2.98003468 |
| 111 | respiratory burst (GO:0045730) | 2.97994953 |
| 112 | positive regulation of neutrophil migration (GO:1902624) | 2.97598910 |
| 113 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.97598910 |
| 114 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96787106 |
| 115 | regulation of female gonad development (GO:2000194) | 2.96220570 |
| 116 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.95501980 |
| 117 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.95138414 |
| 118 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.95014412 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94040820 |
| 120 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.93007556 |
| 121 | regulation of necroptotic process (GO:0060544) | 2.92191240 |
| 122 | mature B cell differentiation (GO:0002335) | 2.91615055 |
| 123 | definitive hemopoiesis (GO:0060216) | 2.90104892 |
| 124 | N-glycan processing (GO:0006491) | 2.89606193 |
| 125 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89438159 |
| 126 | Golgi transport vesicle coating (GO:0048200) | 2.89018634 |
| 127 | COPI coating of Golgi vesicle (GO:0048205) | 2.89018634 |
| 128 | natural killer cell differentiation (GO:0001779) | 2.88500603 |
| 129 | N-acetylneuraminate metabolic process (GO:0006054) | 2.87565565 |
| 130 | regulation of RIG-I signaling pathway (GO:0039535) | 2.87071315 |
| 131 | B cell proliferation (GO:0042100) | 2.86863775 |
| 132 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.86650608 |
| 133 | neutrophil activation involved in immune response (GO:0002283) | 2.86448381 |
| 134 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.86062930 |
| 135 | purine ribonucleotide transport (GO:0015868) | 2.85975823 |
| 136 | mast cell activation (GO:0045576) | 2.85808469 |
| 137 | regulation of type 2 immune response (GO:0002828) | 2.85538776 |
| 138 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84496209 |
| 139 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84496209 |
| 140 | positive thymic T cell selection (GO:0045059) | 2.84166375 |
| 141 | embryonic process involved in female pregnancy (GO:0060136) | 2.80366160 |
| 142 | phenylpropanoid metabolic process (GO:0009698) | 2.79372528 |
| 143 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.79354965 |
| 144 | regulation of prostaglandin secretion (GO:0032306) | 2.79128534 |
| 145 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.78660548 |
| 146 | negative T cell selection (GO:0043383) | 2.78463870 |
| 147 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.76824484 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.76451533 |
| 149 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.75573636 |
| 150 | positive regulation of granulocyte differentiation (GO:0030854) | 2.74733096 |
| 151 | dendritic cell migration (GO:0036336) | 2.74239116 |
| 152 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.73469408 |
| 153 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.72109595 |
| 154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71717142 |
| 155 | positive regulation of nuclease activity (GO:0032075) | 2.71709627 |
| 156 | response to vitamin E (GO:0033197) | 2.70529789 |
| 157 | positive regulation of type 2 immune response (GO:0002830) | 2.70442156 |
| 158 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70124242 |
| 159 | glycosphingolipid biosynthetic process (GO:0006688) | 2.69089551 |
| 160 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.67164739 |
| 161 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.66354880 |
| 162 | mature B cell differentiation involved in immune response (GO:0002313) | 2.64324864 |
| 163 | bone resorption (GO:0045453) | 2.64232882 |
| 164 | response to interleukin-15 (GO:0070672) | 2.64015546 |
| 165 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.63961369 |
| 166 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.63880135 |
| 167 | cellular response to unfolded protein (GO:0034620) | 2.62103907 |
| 168 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.61333134 |
| 169 | positive regulation of Rap GTPase activity (GO:0032854) | 2.59778076 |
| 170 | mast cell degranulation (GO:0043303) | 2.58883149 |
| 171 | mast cell activation involved in immune response (GO:0002279) | 2.58883149 |
| 172 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.58372250 |
| 173 | negative regulation of cell killing (GO:0031342) | 2.58372250 |
| 174 | fucosylation (GO:0036065) | 2.56631043 |
| 175 | hepatocyte apoptotic process (GO:0097284) | 2.55648297 |
| 176 | monocyte differentiation (GO:0030224) | 2.55535053 |
| 177 | regulation of nuclease activity (GO:0032069) | 2.55142722 |
| 178 | positive regulation of B cell activation (GO:0050871) | 2.55094776 |
| 179 | fucose metabolic process (GO:0006004) | 2.54420371 |
| 180 | complement activation (GO:0006956) | 15.7997677 |
| 181 | protein activation cascade (GO:0072376) | 10.1939544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.88039158 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.85127264 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.61146285 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.54816131 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36809650 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.34235152 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30760600 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.29459041 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.62629398 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.51908819 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47594065 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.46846952 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.05642009 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01131367 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.96419274 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.89088310 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.57553024 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56477308 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.56150212 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.53628124 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50153378 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44497941 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.42723224 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.38074057 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.37692985 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.33039110 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28639730 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26205188 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.25042193 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.24422055 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17600097 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17056740 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08660853 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.04120424 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03989359 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.90742715 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88205733 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84242433 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82515146 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81939704 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.80149314 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75275759 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73757833 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73604530 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71231649 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70356592 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68734355 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65151924 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.64113044 |
| 50 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60259179 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58078368 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57133880 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52223170 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51515827 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.51198343 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50667226 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.47870317 |
| 58 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.46801957 |
| 59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46250258 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44851495 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44126012 |
| 62 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43723757 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39757838 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38460893 |
| 65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36619349 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35257048 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34479729 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34322408 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33521345 |
| 70 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32497081 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.31906072 |
| 72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31764141 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31201756 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30838070 |
| 75 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.30426244 |
| 76 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.29785007 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27807173 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27367695 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23414030 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22597264 |
| 81 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21827431 |
| 82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21775566 |
| 83 | MAF_26560356_Chip-Seq_TH2_Human | 1.20890653 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19637233 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19393836 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14465708 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13071855 |
| 88 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.12202217 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11075143 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09761476 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09486512 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09177604 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08979366 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06126799 |
| 95 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05831429 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04414764 |
| 97 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.03664159 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03298820 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02325728 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01839883 |
| 101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01078563 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00874813 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99344146 |
| 104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99245691 |
| 105 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99227542 |
| 106 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98250330 |
| 107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98205535 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.96902378 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95901080 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95274249 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94582315 |
| 112 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93009546 |
| 113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91570251 |
| 114 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91487318 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90465138 |
| 116 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90127200 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89427531 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84550713 |
| 119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84318282 |
| 120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82083579 |
| 121 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81233438 |
| 122 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80270269 |
| 123 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80111109 |
| 124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79989015 |
| 125 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.77600347 |
| 126 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77148289 |
| 127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77104584 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76188065 |
| 129 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74474216 |
| 130 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.74284312 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74254973 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72560351 |
| 133 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.71917252 |
| 134 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.71647096 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.71615486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.14735621 |
| 2 | MP0001800_abnormal_humoral_immune | 4.59553048 |
| 3 | MP0003303_peritoneal_inflammation | 4.11666523 |
| 4 | MP0009697_abnormal_copulation | 3.88108225 |
| 5 | MP0002452_abnormal_antigen_presenting | 3.41539484 |
| 6 | MP0005084_abnormal_gallbladder_morpholo | 3.31808962 |
| 7 | MP0005671_abnormal_response_to | 3.13382808 |
| 8 | MP0001790_abnormal_immune_system | 3.13163120 |
| 9 | MP0005387_immune_system_phenotype | 3.13163120 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.06764885 |
| 11 | MP0002723_abnormal_immune_serum | 2.95529691 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.85248610 |
| 13 | MP0002398_abnormal_bone_marrow | 2.85057372 |
| 14 | MP0001819_abnormal_immune_cell | 2.81944457 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.74357114 |
| 16 | MP0000685_abnormal_immune_system | 2.70927128 |
| 17 | MP0000716_abnormal_immune_system | 2.66395223 |
| 18 | MP0006054_spinal_hemorrhage | 2.61604132 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.57674632 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.56208438 |
| 21 | MP0000689_abnormal_spleen_morphology | 2.34121070 |
| 22 | MP0005025_abnormal_response_to | 2.33950179 |
| 23 | MP0002429_abnormal_blood_cell | 2.22553331 |
| 24 | MP0002419_abnormal_innate_immunity | 2.19118080 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 2.19038434 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.15786486 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 2.10067968 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.04631355 |
| 29 | MP0002722_abnormal_immune_system | 2.04339161 |
| 30 | MP0003436_decreased_susceptibility_to | 2.02701054 |
| 31 | MP0002006_tumorigenesis | 2.01629277 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.98475953 |
| 33 | MP0001879_abnormal_lymphatic_vessel | 1.92247894 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.91536270 |
| 35 | MP0000681_abnormal_thyroid_gland | 1.88113338 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.81163885 |
| 37 | MP0008058_abnormal_DNA_repair | 1.77850308 |
| 38 | MP0004947_skin_inflammation | 1.69034311 |
| 39 | MP0002405_respiratory_system_inflammati | 1.67449010 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.64500777 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.59478400 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.56536231 |
| 43 | MP0009785_altered_susceptibility_to | 1.48967541 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.48886827 |
| 45 | MP0006082_CNS_inflammation | 1.44473509 |
| 46 | MP0006292_abnormal_olfactory_placode | 1.43757904 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.39462271 |
| 48 | MP0001764_abnormal_homeostasis | 1.37367158 |
| 49 | MP0002132_abnormal_respiratory_system | 1.35069976 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.33868182 |
| 51 | MP0004147_increased_porphyrin_level | 1.32614027 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.31778675 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.31664098 |
| 54 | MP0003252_abnormal_bile_duct | 1.28611356 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 1.27795226 |
| 56 | MP0000490_abnormal_crypts_of | 1.26758930 |
| 57 | MP0003045_fibrosis | 1.25188727 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.23373025 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.20617906 |
| 60 | MP0008057_abnormal_DNA_replication | 1.16761503 |
| 61 | MP0009764_decreased_sensitivity_to | 1.12476274 |
| 62 | MP0001873_stomach_inflammation | 1.11896454 |
| 63 | MP0005310_abnormal_salivary_gland | 1.11856813 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.10616463 |
| 65 | MP0002009_preneoplasia | 1.09068048 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 1.08547033 |
| 67 | MP0000613_abnormal_salivary_gland | 1.08240227 |
| 68 | MP0003690_abnormal_glial_cell | 1.07667309 |
| 69 | MP0005166_decreased_susceptibility_to | 1.06934849 |
| 70 | MP0002653_abnormal_ependyma_morphology | 1.06027482 |
| 71 | MP0003866_abnormal_defecation | 1.05259310 |
| 72 | MP0001853_heart_inflammation | 1.05081139 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 1.03986363 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.02428039 |
| 75 | MP0002933_joint_inflammation | 1.01337005 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.01215463 |
| 77 | MP0009379_abnormal_foot_pigmentation | 1.00547339 |
| 78 | MP0002822_catalepsy | 1.00011733 |
| 79 | MP0003724_increased_susceptibility_to | 0.99689979 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.97198301 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.95737212 |
| 82 | MP0001188_hyperpigmentation | 0.94878681 |
| 83 | MP0003075_altered_response_to | 0.94808901 |
| 84 | MP0003787_abnormal_imprinting | 0.94063415 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.93196031 |
| 86 | MP0000858_altered_metastatic_potential | 0.92864278 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.92511880 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.92511880 |
| 89 | MP0000920_abnormal_myelination | 0.89204358 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.88878187 |
| 91 | MP0008469_abnormal_protein_level | 0.88229196 |
| 92 | MP0001664_abnormal_digestion | 0.86261934 |
| 93 | MP0008872_abnormal_physiological_respon | 0.86123201 |
| 94 | MP0005535_abnormal_body_temperature | 0.82173759 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.81709484 |
| 96 | MP0001663_abnormal_digestive_system | 0.81685730 |
| 97 | MP0005266_abnormal_metabolism | 0.79724204 |
| 98 | MP0009278_abnormal_bone_marrow | 0.77591413 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.77056169 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.76039750 |
| 101 | MP0003186_abnormal_redox_activity | 0.75498684 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.75448452 |
| 103 | MP0001851_eye_inflammation | 0.73843534 |
| 104 | MP0008873_increased_physiological_sensi | 0.71780642 |
| 105 | MP0010307_abnormal_tumor_latency | 0.70377666 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.69362750 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.69117281 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.68827601 |
| 109 | MP0000609_abnormal_liver_physiology | 0.68724628 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.68672060 |
| 111 | MP0000313_abnormal_cell_death | 0.68613134 |
| 112 | MP0001919_abnormal_reproductive_system | 0.68015206 |
| 113 | MP0008877_abnormal_DNA_methylation | 0.68012249 |
| 114 | MP0000604_amyloidosis | 0.67874987 |
| 115 | MP0002083_premature_death | 0.66789979 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.65155011 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65085656 |
| 118 | MP0004233_abnormal_muscle_weight | 0.63697215 |
| 119 | MP0003077_abnormal_cell_cycle | 0.63248666 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.62851604 |
| 121 | MP0008569_lethality_at_weaning | 0.62404294 |
| 122 | MP0000343_altered_response_to | 0.62306284 |
| 123 | MP0001905_abnormal_dopamine_level | 0.61821495 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.61711273 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.61375116 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.59885553 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.59612614 |
| 128 | MP0008007_abnormal_cellular_replicative | 0.59418905 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.59269863 |
| 130 | MP0001881_abnormal_mammary_gland | 0.59000065 |
| 131 | MP0003315_abnormal_perineum_morphology | 0.58158299 |
| 132 | MP0005410_abnormal_fertilization | 0.57843644 |
| 133 | MP0009763_increased_sensitivity_to | 0.56365320 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.55641997 |
| 135 | MP0000350_abnormal_cell_proliferation | 0.54657176 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.53905282 |
| 137 | MP0005360_urolithiasis | 0.52352577 |
| 138 | MP0005388_respiratory_system_phenotype | 0.51336589 |
| 139 | MP0002133_abnormal_respiratory_system | 0.51336589 |
| 140 | MP0009643_abnormal_urine_homeostasis | 0.50965363 |
| 141 | MP0003448_altered_tumor_morphology | 0.49378872 |
| 142 | MP0000598_abnormal_liver_morphology | 0.48851439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.29586103 |
| 2 | B lymphocytopenia (HP:0010976) | 7.87574264 |
| 3 | Abnormality of B cell number (HP:0010975) | 7.87574264 |
| 4 | Colitis (HP:0002583) | 6.49771560 |
| 5 | Recurrent sinusitis (HP:0011108) | 6.20595914 |
| 6 | Cellulitis (HP:0100658) | 6.07141628 |
| 7 | IgM deficiency (HP:0002850) | 6.05949538 |
| 8 | Recurrent bronchitis (HP:0002837) | 5.84154423 |
| 9 | Recurrent viral infections (HP:0004429) | 5.52138515 |
| 10 | Papilloma (HP:0012740) | 5.35982372 |
| 11 | Verrucae (HP:0200043) | 5.35982372 |
| 12 | Meningitis (HP:0001287) | 4.88357993 |
| 13 | Acute lymphatic leukemia (HP:0006721) | 4.83375489 |
| 14 | Inflammation of the large intestine (HP:0002037) | 4.76403039 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 4.62304971 |
| 16 | Gastrointestinal inflammation (HP:0004386) | 4.61216578 |
| 17 | Recurrent pneumonia (HP:0006532) | 4.39332418 |
| 18 | Chronic otitis media (HP:0000389) | 4.00460126 |
| 19 | Thyroiditis (HP:0100646) | 3.91780349 |
| 20 | Prostate neoplasm (HP:0100787) | 3.65540969 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.62501982 |
| 22 | Osteomyelitis (HP:0002754) | 3.62277465 |
| 23 | Mesangial abnormality (HP:0001966) | 3.55505234 |
| 24 | Recurrent lower respiratory tract infections (HP:0002783) | 3.50539720 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.47807198 |
| 26 | Recurrent abscess formation (HP:0002722) | 3.35856186 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 3.28260209 |
| 28 | Chronic sinusitis (HP:0011109) | 3.27626993 |
| 29 | IgA deficiency (HP:0002720) | 3.24397177 |
| 30 | Bronchitis (HP:0012387) | 3.20459754 |
| 31 | IgG deficiency (HP:0004315) | 3.17981540 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.15997112 |
| 33 | Sepsis (HP:0100806) | 3.14808279 |
| 34 | Recurrent bacterial skin infections (HP:0005406) | 3.14217855 |
| 35 | Recurrent otitis media (HP:0000403) | 3.12611390 |
| 36 | Myositis (HP:0100614) | 3.12545236 |
| 37 | Increased intramyocellular lipid droplets (HP:0012240) | 3.09343138 |
| 38 | Abnormality of T cells (HP:0002843) | 3.04406972 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.03407649 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.97706950 |
| 41 | Skin rash (HP:0000988) | 2.88367878 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.86234630 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.85340400 |
| 44 | Vasculitis (HP:0002633) | 2.84136498 |
| 45 | Thrombocytosis (HP:0001894) | 2.84056202 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83748878 |
| 47 | Emphysema (HP:0002097) | 2.77587224 |
| 48 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.70308981 |
| 49 | Nasal polyposis (HP:0100582) | 2.68484387 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.64304203 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64304203 |
| 52 | Polygenic inheritance (HP:0010982) | 2.64165539 |
| 53 | Cerebral palsy (HP:0100021) | 2.62298015 |
| 54 | Thoracic kyphosis (HP:0002942) | 2.62163472 |
| 55 | Urticaria (HP:0001025) | 2.61302676 |
| 56 | Lymphopenia (HP:0001888) | 2.60267188 |
| 57 | Metaphyseal dysplasia (HP:0100255) | 2.58667275 |
| 58 | Erythema (HP:0010783) | 2.54223913 |
| 59 | Recurrent skin infections (HP:0001581) | 2.53265963 |
| 60 | Acute hepatic failure (HP:0006554) | 2.49372135 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48128232 |
| 62 | Growth hormone excess (HP:0000845) | 2.46702442 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.41159102 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.35473567 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.32290494 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.30777578 |
| 67 | Restrictive lung disease (HP:0002091) | 2.30054820 |
| 68 | Papilledema (HP:0001085) | 2.30028974 |
| 69 | Thyroid-stimulating hormone excess (HP:0002925) | 2.29809090 |
| 70 | T lymphocytopenia (HP:0005403) | 2.29662518 |
| 71 | Poikiloderma (HP:0001029) | 2.27667482 |
| 72 | Brushfield spots (HP:0001088) | 2.25710625 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.25564447 |
| 74 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.24009485 |
| 75 | Progressive microcephaly (HP:0000253) | 2.23714904 |
| 76 | Cone-rod dystrophy (HP:0000548) | 2.22207157 |
| 77 | Eczematoid dermatitis (HP:0000976) | 2.22057774 |
| 78 | Toxemia of pregnancy (HP:0100603) | 2.21362914 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.20785730 |
| 80 | Type I transferrin isoform profile (HP:0003642) | 2.18489324 |
| 81 | Abnormality of DNA repair (HP:0003254) | 2.16717500 |
| 82 | Skin ulcer (HP:0200042) | 2.16707231 |
| 83 | Neutropenia (HP:0001875) | 2.14998718 |
| 84 | Xerostomia (HP:0000217) | 2.14818519 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.14189364 |
| 86 | Increased IgM level (HP:0003496) | 2.12338808 |
| 87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.12250908 |
| 88 | Eosinophilia (HP:0001880) | 2.10239928 |
| 89 | Cupped ribs (HP:0000887) | 2.10131068 |
| 90 | Decreased central vision (HP:0007663) | 2.03077775 |
| 91 | Menstrual irregularities (HP:0000858) | 1.97812541 |
| 92 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96740403 |
| 93 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96740403 |
| 94 | Increased hepatocellular lipid droplets (HP:0006565) | 1.96417823 |
| 95 | Stomatitis (HP:0010280) | 1.96252008 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96068471 |
| 97 | Obstructive lung disease (HP:0006536) | 1.96068471 |
| 98 | Abnormality of macrophages (HP:0004311) | 1.95111015 |
| 99 | Hypoplasia of the thymus (HP:0000778) | 1.94738736 |
| 100 | Severe combined immunodeficiency (HP:0004430) | 1.93656149 |
| 101 | Central scotoma (HP:0000603) | 1.93075275 |
| 102 | Bronchiectasis (HP:0002110) | 1.92546582 |
| 103 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91500724 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91500724 |
| 105 | Abnormality of lateral ventricle (HP:0030047) | 1.90656259 |
| 106 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.90460746 |
| 107 | Combined immunodeficiency (HP:0005387) | 1.89552306 |
| 108 | Hyperpituitarism (HP:0010514) | 1.88314427 |
| 109 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86194846 |
| 110 | Rhabdomyolysis (HP:0003201) | 1.86069753 |
| 111 | Viral hepatitis (HP:0006562) | 1.84905599 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 1.84312677 |
| 113 | Mutism (HP:0002300) | 1.79133363 |
| 114 | Mucosal telangiectasiae (HP:0100579) | 1.79096650 |
| 115 | Vacuolated lymphocytes (HP:0001922) | 1.78102665 |
| 116 | Autoimmune hemolytic anemia (HP:0001890) | 1.77386038 |
| 117 | Vertebral compression fractures (HP:0002953) | 1.77186856 |
| 118 | Spondylolisthesis (HP:0003302) | 1.76251127 |
| 119 | Acrocyanosis (HP:0001063) | 1.74742049 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.74491908 |
| 121 | Hepatic necrosis (HP:0002605) | 1.73273221 |
| 122 | Lymphoma (HP:0002665) | 1.73255317 |
| 123 | Lipid accumulation in hepatocytes (HP:0006561) | 1.73150963 |
| 124 | Arthralgia (HP:0002829) | 1.72825661 |
| 125 | Abnormality of macular pigmentation (HP:0008002) | 1.72264028 |
| 126 | Leukopenia (HP:0001882) | 1.71944736 |
| 127 | Hepatocellular necrosis (HP:0001404) | 1.71899962 |
| 128 | Petechiae (HP:0000967) | 1.71713352 |
| 129 | Abnormality of eosinophils (HP:0001879) | 1.71073168 |
| 130 | Enlarged epiphyses (HP:0010580) | 1.70870978 |
| 131 | Optic neuritis (HP:0100653) | 1.69045699 |
| 132 | Retrobulbar optic neuritis (HP:0100654) | 1.69045699 |
| 133 | Increased IgE level (HP:0003212) | 1.67633356 |
| 134 | Disinhibition (HP:0000734) | 1.65692470 |
| 135 | Mitral stenosis (HP:0001718) | 1.64196496 |
| 136 | Abnormal foot bone ossification (HP:0010675) | 1.62908932 |
| 137 | Granulocytopenia (HP:0001913) | 1.61908177 |
| 138 | Encephalitis (HP:0002383) | 1.60259324 |
| 139 | Orchitis (HP:0100796) | 1.59454314 |
| 140 | Periodontitis (HP:0000704) | 1.58655626 |
| 141 | Leukocytosis (HP:0001974) | 1.57006170 |
| 142 | Exercise-induced myalgia (HP:0003738) | 1.56621116 |
| 143 | Hypergammaglobulinemia (HP:0010702) | 1.55908675 |
| 144 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.51693431 |
| 145 | Arterial thrombosis (HP:0004420) | 1.49192839 |
| 146 | Easy fatigability (HP:0003388) | 1.47612877 |
| 147 | Autoimmune thrombocytopenia (HP:0001973) | 1.45620369 |
| 148 | Increased cerebral lipofuscin (HP:0011813) | 1.43324937 |
| 149 | Abnormality of the fingertips (HP:0001211) | 1.42090309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.41895832 |
| 2 | MAP4K2 | 4.96186265 |
| 3 | MAP4K1 | 4.47509309 |
| 4 | BMPR2 | 4.24242971 |
| 5 | VRK2 | 3.33777868 |
| 6 | TAOK3 | 2.87212687 |
| 7 | RIPK4 | 2.73625248 |
| 8 | GRK6 | 2.67607995 |
| 9 | KDR | 2.62606789 |
| 10 | TYK2 | 2.58151080 |
| 11 | TESK2 | 2.38193516 |
| 12 | SYK | 2.33768087 |
| 13 | BTK | 2.28709173 |
| 14 | BLK | 2.24353851 |
| 15 | ITK | 2.18645234 |
| 16 | SCYL2 | 2.18505347 |
| 17 | CSF1R | 2.12859865 |
| 18 | KIT | 2.10496263 |
| 19 | IRAK4 | 2.01391104 |
| 20 | MAP3K10 | 1.90721903 |
| 21 | STK10 | 1.82537176 |
| 22 | IKBKE | 1.70462533 |
| 23 | CDC7 | 1.68842500 |
| 24 | MAP3K14 | 1.68447755 |
| 25 | PIM2 | 1.57070036 |
| 26 | CLK1 | 1.56417583 |
| 27 | CCNB1 | 1.49878248 |
| 28 | TXK | 1.48980200 |
| 29 | SIK2 | 1.48809619 |
| 30 | IKBKB | 1.45225377 |
| 31 | TBK1 | 1.44191549 |
| 32 | TGFBR2 | 1.36734553 |
| 33 | HIPK2 | 1.36616211 |
| 34 | NME2 | 1.32722585 |
| 35 | HCK | 1.31887976 |
| 36 | FGFR3 | 1.31633389 |
| 37 | PIK3CG | 1.31377437 |
| 38 | MAP3K11 | 1.30790967 |
| 39 | TEC | 1.30531240 |
| 40 | JAK1 | 1.29586042 |
| 41 | IRAK3 | 1.25829645 |
| 42 | LYN | 1.25464028 |
| 43 | MAP3K13 | 1.22087849 |
| 44 | JAK3 | 1.21644682 |
| 45 | EEF2K | 1.20160210 |
| 46 | EIF2AK3 | 1.18976276 |
| 47 | TNK2 | 1.18520961 |
| 48 | DMPK | 1.18278575 |
| 49 | DAPK1 | 1.13610100 |
| 50 | FES | 1.12816628 |
| 51 | PIM1 | 1.09195391 |
| 52 | NEK2 | 1.05342810 |
| 53 | CDK9 | 1.00184838 |
| 54 | LCK | 0.91165094 |
| 55 | MAPK15 | 0.89301219 |
| 56 | EPHB1 | 0.81517327 |
| 57 | PRKCH | 0.77630210 |
| 58 | CDK4 | 0.77469582 |
| 59 | NEK9 | 0.77457997 |
| 60 | FGFR4 | 0.77288998 |
| 61 | PRKCQ | 0.76827283 |
| 62 | TESK1 | 0.75926045 |
| 63 | NUAK1 | 0.73747846 |
| 64 | MAP3K5 | 0.73244270 |
| 65 | MAPK7 | 0.73106417 |
| 66 | PBK | 0.72613696 |
| 67 | FRK | 0.71831867 |
| 68 | TRPM7 | 0.71134735 |
| 69 | BUB1 | 0.70670904 |
| 70 | ALK | 0.70452375 |
| 71 | ADRBK2 | 0.69498254 |
| 72 | CSK | 0.69383560 |
| 73 | GSK3A | 0.69329931 |
| 74 | FLT3 | 0.69176446 |
| 75 | LRRK2 | 0.67579699 |
| 76 | PINK1 | 0.66298759 |
| 77 | MAP2K6 | 0.62289935 |
| 78 | PDK2 | 0.59576277 |
| 79 | PRKD1 | 0.58973512 |
| 80 | CHUK | 0.58968038 |
| 81 | OXSR1 | 0.58936907 |
| 82 | VRK1 | 0.58631303 |
| 83 | MAPK4 | 0.58409724 |
| 84 | RPS6KL1 | 0.57305865 |
| 85 | RPS6KC1 | 0.57305865 |
| 86 | RPS6KA6 | 0.57021351 |
| 87 | ZAP70 | 0.56158630 |
| 88 | RPS6KA4 | 0.55804934 |
| 89 | TAF1 | 0.54705932 |
| 90 | JAK2 | 0.53923772 |
| 91 | TNIK | 0.53093248 |
| 92 | GRK5 | 0.52905081 |
| 93 | BMX | 0.52372780 |
| 94 | PDK1 | 0.51845545 |
| 95 | MATK | 0.49671240 |
| 96 | ABL2 | 0.48777851 |
| 97 | TRIB3 | 0.48138244 |
| 98 | STK4 | 0.47801498 |
| 99 | MAP3K8 | 0.47078839 |
| 100 | DYRK1B | 0.46703130 |
| 101 | CDK12 | 0.46490601 |
| 102 | EIF2AK2 | 0.46460398 |
| 103 | CDK8 | 0.42804938 |
| 104 | CDK19 | 0.41786982 |
| 105 | FYN | 0.40887255 |
| 106 | SGK3 | 0.40847057 |
| 107 | CDK6 | 0.40736196 |
| 108 | MAP2K4 | 0.40691368 |
| 109 | MAPK12 | 0.40608195 |
| 110 | BMPR1B | 0.39599334 |
| 111 | TIE1 | 0.39475096 |
| 112 | MAP3K12 | 0.39446015 |
| 113 | TGFBR1 | 0.39376011 |
| 114 | MAPKAPK2 | 0.39080163 |
| 115 | AKT3 | 0.38854007 |
| 116 | MAPK3 | 0.38770363 |
| 117 | RPS6KA5 | 0.38735050 |
| 118 | BCKDK | 0.37191865 |
| 119 | GRK7 | 0.36731732 |
| 120 | FGFR2 | 0.35857486 |
| 121 | PRKCD | 0.35244117 |
| 122 | CDK7 | 0.33919680 |
| 123 | BRSK2 | 0.33700232 |
| 124 | PTK6 | 0.33298571 |
| 125 | RPS6KA2 | 0.33170876 |
| 126 | CSNK2A2 | 0.32192600 |
| 127 | ADRBK1 | 0.31733116 |
| 128 | RPS6KB1 | 0.30438710 |
| 129 | ATR | 0.30131227 |
| 130 | PRKD2 | 0.30023192 |
| 131 | RPS6KB2 | 0.29529169 |
| 132 | BRSK1 | 0.29523463 |
| 133 | AKT2 | 0.29491926 |
| 134 | CSNK2A1 | 0.29262790 |
| 135 | MAPK11 | 0.28413623 |
| 136 | PAK4 | 0.28015837 |
| 137 | ABL1 | 0.28013812 |
| 138 | MAP2K3 | 0.27460211 |
| 139 | EIF2AK1 | 0.26074060 |
| 140 | INSRR | 0.25181438 |
| 141 | MAP3K1 | 0.25165689 |
| 142 | IGF1R | 0.25163598 |
| 143 | MAP3K7 | 0.24059286 |
| 144 | TLK1 | 0.23119454 |
| 145 | PRKCA | 0.22246696 |
| 146 | DYRK3 | 0.20756255 |
| 147 | CSNK1A1 | 0.19074012 |
| 148 | STK39 | 0.17714429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.66423929 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.69234895 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.95935113 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.65146622 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.13207570 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.56393583 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.43131371 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.39618213 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.13162263 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.94896581 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.94437776 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88894649 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86520414 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81428015 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.73728994 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.58131784 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57642609 |
| 18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.55169290 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47947963 |
| 20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46983188 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45094460 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45009378 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43473981 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.43372533 |
| 25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35476214 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.35158107 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.32908510 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31301806 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28405305 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27607126 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25862587 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.24974052 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.24686682 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16702871 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.15280588 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13418755 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12062059 |
| 38 | RNA polymerase_Homo sapiens_hsa03020 | 1.08744526 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.08611907 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08254251 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 1.07301421 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04896105 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03378159 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01870489 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01558481 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01313867 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.99419634 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98787915 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98245799 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.98222921 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.97319489 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95287199 |
| 53 | Mismatch repair_Homo sapiens_hsa03430 | 0.95147239 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.93094586 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91299041 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90467110 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.90267703 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.89161603 |
| 59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84410695 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83630219 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82556038 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74989193 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.74422226 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73920095 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72510444 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72454909 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.71917609 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71362932 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.69946715 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68731071 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.68614984 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67842101 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66307901 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66112868 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66028485 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63796113 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63055497 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62575465 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.61940177 |
| 80 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60966297 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60755003 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60665817 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60577019 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60556287 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60184026 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59714293 |
| 87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59563997 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58738760 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58337453 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58238128 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58121968 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57052051 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56996816 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56728458 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55101983 |
| 96 | Influenza A_Homo sapiens_hsa05164 | 0.54393834 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54195392 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52561894 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52244067 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50828440 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49378196 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49033611 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47685092 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.45933326 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45900439 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45737954 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44718337 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.44390643 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43211210 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42904457 |
| 111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41506547 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40844140 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.40696825 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39397305 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39388947 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38792040 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38586764 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38330720 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37551459 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.37017781 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36980578 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36592932 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36196421 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36176675 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34399706 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31911585 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31712147 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.29889546 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29538967 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29099756 |
| 131 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28956576 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.27111627 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.26811695 |
| 134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26585396 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.26106332 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25998388 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25964348 |
| 138 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25167955 |
| 139 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22392803 |
| 140 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22067007 |
| 141 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21162460 |
| 142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20901171 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.20747294 |
| 144 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.19478688 |
| 145 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16625260 |
| 146 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16398140 |
| 147 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.12020036 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.10392891 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.09958131 |
| 150 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09714386 |
| 151 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.08518135 |

